No credit card. No commitment.
5000+ G2 reviews
Monopteros Therapeutics
Research
Founded in 2019
Boston, Massachusetts
monopterostx.comMonopteros Therapeutics
ResearchFounded in 2019Boston, Massachusetts
EmployeesMonopteros Therapeutics' financial review
Monopteros Therapeutics information
Monopteros Therapeutics is a clinical-stage biotechnology company developing a first-in-class inhibitor of MALT1 protease. The company's first asset MPT-0118, is conducting a phase 1 clinical trial to investigate reprogramming regulatory T cells in solid tumors.
Monopteros Therapeutics industries
Research
Biotechnology research
Monopteros Therapeutics' financial review
Employee Metrics
Technologies
Email Providers
Other
Other
Fonts
Load Balancers
Notable Alumni
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
